IC19: Neuropharmacology in the Rehab Setting: A General Overview of Various Treatments and Discussion of New Treatment Options

Sunday, October 26, 2025

8:30 AM - 5:30 PM

Location: ROOM: Williford B >>> DIRECTIONS: Third Floor >>> From the Main Elevator Bank, proceed left. Williford B is the second room on your right.

Corresponding Presenter(s)

Joseph Rosenthal, MD/MPH (he/him/his)

Associate Professor
University of Colorado
Aurora, CO, United States

Slides Slides

Presenter(s)

William Niehaus, MD

Outpatient Medical Director and Chief Innovation Catalyst
University of Colorado Department of Physical Medicine and Rehabilitation
Denver, Colorado, United States

Slides Slides
Delia Bakeman, DO (she/her/hers)

Assistant Professor Neurology and Psychiatry
University of Colorado-Anschutz
Lafayette, CO, United States

Slides Slides
Victor W. Mark, MD (he/him/his)

Associate Professor
University of Alabama at Birmingham
Birmingham, Alabama, United States

Slides Slides
Sheryl D. Katta-Charles, MD (she/her/hers)

Brain Injury Medical Director, Assistant Program Director, Assistant Clinical Professor
Indiana University School of Medicine
Indianapolis, IN, United States

Slides Slides
Eboni A. Reed

Assistant Professor, Attending Physician
UT Houston, TIRR Memorial Hermann
Houston, TX, United States

Slides Slides
Sheital Bavishi, DO

Associate Professor-Clinical, Medical Director Brain Injury Program, Residency Program Director
Ohio State University College of Medicine and Wexner Medical Center
Columbus, Ohio, United States

Slides Slides
Alice Kam, MD, MScCH (HPTE), FRCPC (she/her/hers)

Assistant Professor
University of Toronto
Toronto, Ontario, Canada

Slides Slides
Edison H. Wong, MD, MS (he/him/his)

Chief Medical Officer
MD Diagnostic Specialists
Orlando, FL, United States

Slides Slides

This instructional course will provide an overview of Neuropharmacology, a broad umbrella term for medications used to treat various neurologic conditions. The course will cover general concepts such as neurotransmitters, polypharmacy, and functional recovery. It will also discuss pharmacologic treatment options available for specific neurologic conditions such as stroke recovery, movement disorders, spasticity, and others. It is geared for clinicians, physician and non-physician.

Learning Objectives:

Upon completion, participant will be able to describe the various pharmacology options to treat spasticity.
Upon completion, participant will be able to describe the various pharmacology options to manage behavioral changes and cognitive impairments after stroke and brain injury.
Upon completion, participant will be able to describe the various pharmacology options and limitations for management motor recovery after stroke and brain injury.
Upon completion: participant will be able to: 1) explain differences between supplements vs prescription drugs. 2) describe the best practice for prescribing supplements 3) apply best practice to prescribe at least 2 strong evidence-based supplements 4) Compare risk vs benefit for model supplements magnesium and melatonin
Upon completion, participant will be able to 1) Describe masking pathologies of consciousness 2) Utilize medications to treat masking pathologies 3) Create treatment plans for patients with disorders of consciousness using arousal-promoting medications 4) List and detail the mechanism of action, practical dose, and side effects of medications commonly used in DoC